Memgen’s Clinical Results on Leukemia Selected for Presentation at 2008 American Society of Hematology Annual Meeting

December 3, 2008 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

DALLAS--(BUSINESS WIRE)--Memgen today announced that two of its clinical trials were selected for poster presentations at the annual meeting of the American Society of Hematology (ASH) on December 6-9.

Twitter
LinkedIn
Facebook
Email
Print